168 related articles for article (PubMed ID: 27008005)
1. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).
Qi WX; Zhang Q; Li P; Zhang XM; Zhang GY; Wu B; Lu JJ; Jiang GL; Fu S
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1361-7. PubMed ID: 27008005
[TBL] [Abstract][Full Text] [Related]
2. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
Song I; Kim CK; Park BK; Park W
AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.
Kim AY; Kim CK; Park SY; Park BK
AJR Am J Roentgenol; 2014 Dec; 203(6):W645-50. PubMed ID: 25415730
[TBL] [Abstract][Full Text] [Related]
4. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
[TBL] [Abstract][Full Text] [Related]
6. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
[TBL] [Abstract][Full Text] [Related]
9. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy.
Onal C; Erbay G; Guler OC; Oymak E
Radiother Oncol; 2022 Aug; 173():285-291. PubMed ID: 35753556
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy.
Iraha Y; Murayama S; Kamiya A; Iraha S; Ogawa K
Anticancer Res; 2012 Oct; 32(10):4467-71. PubMed ID: 23060574
[TBL] [Abstract][Full Text] [Related]
13. The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients.
Onal C; Erbay G; Oymak E; Guler OC
Radiother Oncol; 2023 Jul; 184():109677. PubMed ID: 37084886
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
[TBL] [Abstract][Full Text] [Related]
15. Triage of low-risk prostate cancer patients with PSA levels 10 ng/ml or less: comparison of apparent diffusion coefficient value and transrectal ultrasound-guided target biopsy.
Itatani R; Namimoto T; Kajihara H; Katahira K; Kitani K; Hamada Y; Yamashita Y
AJR Am J Roentgenol; 2014 May; 202(5):1051-7. PubMed ID: 24758659
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
17. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
18. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
19. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
Park SY; Kim CK; Park BK; Kwon GY
AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
[TBL] [Abstract][Full Text] [Related]
20. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
Reischauer C; Froehlich JM; Koh DM; Graf N; Padevit C; John H; Binkert CA; Boesiger P; Gutzeit A
Radiology; 2010 Nov; 257(2):523-31. PubMed ID: 20829534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]